Understanding CEAS: Chronic Enteropathy Associated with SLCO2A1

Chronic enteropathy associated with SLCO2A1 (CEAS) is a rare genetic condition that primarily affects the small intestine ^[1][2]. For many years, doctors referred to this condition as chronic nonspecific multiple ulcers of the small intestine (CNSU) ^[3]. The name changed after researchers discovered that the root cause is a mutation in the SLCO2A1 gene, which provides instructions for a protein that helps the body process prostaglandins (lipid mediators derived from fatty acids that are involved in inflammation and blood flow) ^[4][5].

Because CEAS is so rare, many people spend years looking for an answer. It is a chronic condition characterized by the formation of multiple shallow ulcers in the small bowel, leading to persistent loss of blood and protein ^[6][7]. Understanding the nature of this disease is the first step toward managing its long-term effects.

A Rare and Specific Diagnosis

CEAS is exceptionally rare. A nationwide study in Japan estimated its prevalence in that cohort at approximately 3.1 people per million ^[8]. While it affects both men and women nearly equally, it is most commonly diagnosed in individuals of East Asian descent, particularly those of Japanese or Korean heritage ^[8][9]. One review noted that approximately 86% of all reported cases globally have been in Asian populations ^[10]. However, these numbers are estimates from reported cohorts and do not rule out CEAS in other ethnicities.

One of the most difficult aspects of CEAS is the long, frustrating journey to a correct diagnosis. Because it is so uncommon, it is frequently misdiagnosed as Crohn’s disease ^[2]. Both conditions cause abdominal pain and intestinal ulcers, but the underlying causes and treatments are very different. Unlike Crohn’s disease, CEAS often presents with very low markers of inflammation in the blood, such as C-reactive protein (CRP), which can be a key clue for your medical team that something else is going on ^[6][7]. Keep in mind that a low CRP is just a clue; CRP can occasionally be normal in Crohn’s or elevated in CEAS during a complication.

Typical Disease Course

The hallmark of CEAS is the presence of “nonspecific” ulcers—meaning they do not have the specific patterns seen in infections or other autoimmune diseases ^[3]. These ulcers are typically shallow and often appear in a circular or “eccentric” shape around the lining of the small intestine, particularly in the section called the ileum ^[2][6].

As the disease progresses, it often follows a steady, persistent path:

• Persistent Blood Loss: The small ulcers often leak tiny amounts of blood over long periods. This leads to iron-deficiency anemia, which can cause significant fatigue, shortness of breath, and weakness ^[6][7].
• Protein Loss: The damaged intestinal lining also leaks protein into the gut, a condition called protein-losing enteropathy. This results in hypoalbuminemia (low levels of the protein albumin in the blood), which can lead to swelling (edema) in the legs or abdomen ^[6][9].
• Stricture Formation: Over time, the repeated healing and scarring of these ulcers can cause the intestine to narrow. These narrowings, called strictures, can eventually lead to blockages (obstructions) that may require surgical intervention ^[11][2].

Confirming the Diagnosis

In the past, doctors relied solely on what they could see during an endoscopy or on a scan. Today, diagnosis is much more precise. The main confirmatory test for CEAS, when interpreted in the appropriate clinical context, is genetic testing to identify pathogenic variants in both copies of the SLCO2A1 gene ^[3][1].

CEAS follows an autosomal-recessive inheritance pattern. This means if both parents are carriers, each pregnancy has a 25% chance of the child being affected and a 50% chance of being a carrier. Discussing testing of siblings or relatives should be arranged with a genetic counselor.

Doctors may also use a specialized urine test to measure a substance called PGE-MUM ^[12]. Patients with CEAS typically have much higher levels of this marker than those with Crohn’s disease, making it a helpful adjunct tool for distinguishing between the two ^[12]. Some patients also experience symptoms outside the gut, such as digital clubbing (where the fingertips become rounded and bulbous) or periostosis (bone thickening), which can serve as additional physical clues for your doctor ^[6][13].

While a diagnosis of CEAS can be overwhelming, identifying the specific genetic cause allows you and your care team to move away from ineffective treatments for other diseases and focus on managing the symptoms and complications of this specific condition.